HUP0002265A2 - Eljárás plazmafehérjét tartalmazó gyógyszer előállítására - Google Patents

Eljárás plazmafehérjét tartalmazó gyógyszer előállítására

Info

Publication number
HUP0002265A2
HUP0002265A2 HU0002265A HUP0002265A HUP0002265A2 HU P0002265 A2 HUP0002265 A2 HU P0002265A2 HU 0002265 A HU0002265 A HU 0002265A HU P0002265 A HUP0002265 A HU P0002265A HU P0002265 A2 HUP0002265 A2 HU P0002265A2
Authority
HU
Hungary
Prior art keywords
plasma protein
citrate
plasma
producing
containing medicament
Prior art date
Application number
HU0002265A
Other languages
English (en)
Inventor
Herwig Igel
Yendra Linnau
Sonja Svatos
Wolfgang Teschner
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3517640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002265(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Publication of HUP0002265A2 publication Critical patent/HUP0002265A2/hu
Publication of HUP0002265A3 publication Critical patent/HUP0002265A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya eljárás plazmafehérjét tartalmazó, nemkívánatosfémektől lényegében mentes gyógyszer citrátplazmából vagycitráttartalmú plazmafrakcióból történő előállítására, amely akövetkező lépéseket tartalmazza: - plazmafehérjét tartalmazó oldatban lévő citrátok és adott esetbencitráthoz kötött fémek kicserélése vízoldható mono- vagydikarboxilátokra, illetve szerves mono- vagy dikarbonsavakra,csapadékképződést elő nem idéző körülmények között, - a plazmafehérje vagy a plazmafehérjék kinyerése és - a gyógyszer elkészítése. Ó
HU0002265A 1996-09-16 1997-09-10 Process for producing a plasma protein-containing medicament HUP0002265A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0163396A AT403989B (de) 1996-09-16 1996-09-16 Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels

Publications (2)

Publication Number Publication Date
HUP0002265A2 true HUP0002265A2 (hu) 2000-11-28
HUP0002265A3 HUP0002265A3 (en) 2003-01-28

Family

ID=3517640

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002265A HUP0002265A3 (en) 1996-09-16 1997-09-10 Process for producing a plasma protein-containing medicament

Country Status (24)

Country Link
US (3) US20020034809A1 (hu)
EP (1) EP0927195B1 (hu)
JP (1) JP2001500867A (hu)
KR (1) KR20000036002A (hu)
CN (1) CN1230967A (hu)
AR (1) AR009582A1 (hu)
AT (2) AT403989B (hu)
AU (1) AU732519B2 (hu)
BR (1) BR9712044A (hu)
CA (1) CA2265936C (hu)
CZ (1) CZ91199A3 (hu)
DE (1) DE59710700D1 (hu)
DK (1) DK0927195T3 (hu)
ES (1) ES2206701T3 (hu)
HU (1) HUP0002265A3 (hu)
ID (1) ID21224A (hu)
IL (1) IL128770A0 (hu)
IN (1) IN187314B (hu)
MX (1) MXPA99002144A (hu)
NO (1) NO991198L (hu)
PL (1) PL332159A1 (hu)
PT (1) PT927195E (hu)
SK (1) SK32899A3 (hu)
WO (1) WO1998012225A2 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT408946B (de) * 1999-02-18 2002-04-25 Immuno Ag Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
EP1458408B1 (en) 2001-12-21 2009-04-15 Novo Nordisk Health Care AG Liquid composition of factor vii polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
WO2004103398A1 (en) * 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
KR20120104619A (ko) 2003-08-14 2012-09-21 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｖｉｉ 폴리펩티드의 액상 수성 약학적 조성물
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
KR20210134808A (ko) 2011-12-05 2021-11-10 팩터 바이오사이언스 인크. 세포를 형질감염시키는 방법들 및 생성물들
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
EP3668985B1 (en) 2017-08-17 2021-06-16 Just-Evotec Biologics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384134C (de) * 1921-05-07 1923-10-25 Chemisch Pharmazeutische Werke Verfahren zur Herstellung eines Kamillenextraktes
DE2331854A1 (de) * 1973-06-22 1975-01-16 Greither Salus Haus Dr Otto Verfahren zur herstellung standardisierter arzneimittel aus kamillenblueten
FR2630115B1 (fr) 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
SE500110C2 (sv) * 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP2949846B2 (ja) 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5561115A (en) 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
US5744586A (en) * 1996-06-26 1998-04-28 Alpha Therapeutic Corporation Manufacturing process for the production of purified transferrin
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies

Also Published As

Publication number Publication date
CA2265936A1 (en) 1998-03-26
NO991198L (no) 1999-05-14
DE59710700D1 (de) 2003-10-09
ES2206701T3 (es) 2004-05-16
EP0927195B1 (de) 2003-09-03
EP0927195A2 (de) 1999-07-07
ATA163396A (de) 1997-12-15
CA2265936C (en) 2008-04-22
ATE248857T1 (de) 2003-09-15
BR9712044A (pt) 1999-08-24
HUP0002265A3 (en) 2003-01-28
US8709492B2 (en) 2014-04-29
IL128770A0 (en) 2000-01-31
KR20000036002A (ko) 2000-06-26
PT927195E (pt) 2004-01-30
US20050249815A1 (en) 2005-11-10
MXPA99002144A (es) 2005-04-28
CN1230967A (zh) 1999-10-06
NO991198D0 (no) 1999-03-11
US20020034809A1 (en) 2002-03-21
IN187314B (hu) 2002-03-23
JP2001500867A (ja) 2001-01-23
AU4289997A (en) 1998-04-14
SK32899A3 (en) 1999-08-06
CZ91199A3 (cs) 1999-06-16
PL332159A1 (en) 1999-08-30
AR009582A1 (es) 2000-04-26
ID21224A (id) 1999-05-06
WO1998012225A2 (de) 1998-03-26
US20140234292A1 (en) 2014-08-21
AU732519B2 (en) 2001-04-26
AT403989B (de) 1998-07-27
WO1998012225A3 (de) 1998-04-23
DK0927195T3 (da) 2003-11-24

Similar Documents

Publication Publication Date Title
HUP0002265A2 (hu) Eljárás plazmafehérjét tartalmazó gyógyszer előállítására
HUP0301723A2 (hu) Eljárás peptidek előállítására in vitro transzkripciós/transzlációs rendszer alkalmazásával
ES2013346A6 (es) Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
IL95480A0 (en) Process for the preparation of cyclic amino acids,and intermediates
HUP0004338A2 (hu) Raumatoid artritiszben szenvedő betegek széruma által felismert, citrullint tartalmazó szintetikus peptidek diagnosztikai és terápiás alkalmazásai
HUP0103758A2 (hu) Neurotróf faktorok
HUP0101734A2 (hu) Béta-amiloid prekurzor protein és ubiquitin-B kereteltolódásos mutánsok és alkalmazásuk
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
HUT56880A (en) Process for producing biologically active protein
IL173399A (en) Circular dna molecules, processes for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medical products for producing recombinant proteins in vivo
NZ515936A (en) Antigenic Neisserial peptides
AU6871291A (en) Hpth (1-37) fragment, its production, drug containing it and its use
WO1993018146A3 (fr) Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques
PT83255A (en) Process for the preparation of polypeptides and characteristic antibodies of papillomavirus and diagnostic method thereto
HUP9800377A1 (hu) Új növekedési faktor és ezt kódoló génszekvencia
DE69836197D1 (de) Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
DE69903450D1 (de) Verfahren zur rückgewinnung von methylacetat und restlicher essigsäure in der herstellung von reiner terephthalsäure
AU2001232275A1 (en) Novel collagen-like protein clac, precursor thereof and genes encoding the same
AU7649098A (en) Syndecan interacting proteins and the use thereof
DE68913212D1 (de) Ein reines faktor i-protein und verfahren zur herstellung.
JPS6437298A (en) Production of c-terminal amidated peptide
JP3118236B2 (ja) アンジオテンシンｉ変換酵素阻害剤の製造方法
WO2001064875A3 (en) Human transporter genes and proteins encoded thereby